Bioactive Compound Library

A collection of 17760 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;

Well-chosen quantity: only contains 989 bioactive compounds after careful selection

A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsa

A unique collection of 3163 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1796 annotated bioactive compounds with clear targets, suitable for phenotypic screening;

A unique collection of 1133 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents;

A unique collection of 523 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening;

A collection of 26342 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.

438 well-chosen unique anti-parasitic small molecules;

A unique collection of 1106 antibacterial bioactive compounds, a powerful tool for antibacterial drug development;

A unique collection of 2450 anti-obesity compounds for high throughput and high content screening;

A unique collection of 490 osteogenesis related compounds for high throughput and high content screening;

A unique collection of 2240 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening.